Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Consanguineous Marriage Among Familial Multiple Sclerosis Subjects: A National Registry-Based Study Publisher



Salehi Z1, 2 ; Naghizadeh MM3 ; Ezabadi SG4 ; Ebrahimitirtashi A4 ; Abbasi Kasbi N4 ; Khodaie F4 ; Aliyari S5 ; Ashtari F6 ; Baghbanian SM7 ; Nabavi SM8 ; Hosseini S9 ; Razazian N10 ; Shaygannejad V6 ; Majdinasab N11 Show All Authors
Authors
  1. Salehi Z1, 2
  2. Naghizadeh MM3
  3. Ezabadi SG4
  4. Ebrahimitirtashi A4
  5. Abbasi Kasbi N4
  6. Khodaie F4
  7. Aliyari S5
  8. Ashtari F6
  9. Baghbanian SM7
  10. Nabavi SM8
  11. Hosseini S9
  12. Razazian N10
  13. Shaygannejad V6
  14. Majdinasab N11
  15. Harirchian MH12
  16. Bayati A13
  17. Kamali H14
  18. Hosseni Nejad Mir N15
  19. Beladi Moghadam N16
  20. Poursadeghfard M17
  21. Mozhdehipanah H18
  22. Jalali N19
  23. Nahayati MA20
  24. Faraji F21
  25. Kamyari N22
  26. Sahraian MA4
  27. Maghbooli Z4
  28. Eskandarieh S4
Show Affiliations
Authors Affiliations
  1. 1. Hematology, Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Research Institute for Oncology, Hematology and Cell Therapy, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran
  4. 4. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Division of Applied Bioinformatics, German Cancer Research Center DKFZ Heidelberg, Heidelberg, Germany
  6. 6. Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  7. 7. Department of Neurology, Booalicina Hospital, Mazandaran University of Medical Sciences, Sari, Iran
  8. 8. Department of Regenerative Medicine, Royan Institute for Stem Cell Technology and Biology, Tehran, Iran
  9. 9. Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  10. 10. Department of Neurology, School of Medicine, Imam Reza Hospital, Kermanshah University of Medical Sciences, Iran
  11. 11. Musculoskeletal Rehabilitation Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  12. 12. Department of Neurology, School of Medicine, Iranian Center of Neurological Research, Neuroscience Institute, Imam Khomeini Hospital, Tehran University of Medical Sciences, Iran
  13. 13. Department of Neurology, Shahrekord University of Medical Sciences and Health Services, Shahrekord, Iran
  14. 14. Neurology Research Center, Kerman University of Medical Sciences, Kerman, Iran
  15. 15. Department of Internal Medicine, School of Medicine, Shohadaye Ashayer Hospital, Lorestan University of Medical Sciences, Khorramabad, Iran
  16. 16. Department of Neurology, School of Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Iran
  17. 17. Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  18. 18. Department of Neurology, Qazvin University of Medical Sciences, Qazvin, Iran
  19. 19. Department of Neurology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
  20. 20. Department of Neurology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran
  21. 21. Department of Neurology, School of Medicine, Arak University of Medical Sciences, Arak, Iran
  22. 22. Department of Biostatistics and Epidemiology, School of Health, Abadan University of Medical Sciences, Abadan, Iran

Source: Heliyon Published:2024


Abstract

Background: The rising prevalence of familial multiple sclerosis (MS) in Iran has spurred interest in the potential impact of parental consanguinity on the risk of developing the disease. This study aims to aggregate current knowledge on parental consanguinity and its possible effect on MS risk, particularly among familial MS patients from various regions and ethnicities in Iran. The objective is to enhance the understanding of MS genetics and encourage further research in this field. Materials and methods: A cross-sectional study was conducted on clinically definite familial MS (FMS) patients registered in the nationwide MS registry of Iran (NMSRI). Data were extracted and supplemented with structured telephone follow-ups to gather detailed histories of MS in relatives and the familial relationships of the patients' parents. A family penetration score was proposed. Descriptive statistics and inferential statistical tests were used to analyze the data at a significance level of 0.05, adhering to ethical guidelines. Results: Out of 19,911 individuals registered in the NMSRI, 2307 FMS patients across 13 provinces were included in the final analysis. Among these, 385 (19.3 %) reported parental consanguinity, with 283 (14.2 %) having parents who were cousins and 102 (5.1 %) having parents who were distant relatives. The data showed no significant association between parental kinship and variables such as MS phenotype, number of affected relatives with MS, hospitalization rates, and expanded disability status scale score. Similarly, MS severity did not differ based on parental consanguinity (P-value >0.05). While the rate of consanguineous marriage was higher among patients with an onset age less than 18 years, there was no statistically significant difference in disease onset age based on parental consanguinity status. Conclusion: Our study highlights the complexity of factors influencing MS development, including genetic and environmental components. These results highlight the need for further research to achieve a more comprehensive understanding of MS etiology. © 2024 The Authors
Other Related Docs
16. Multiple Sclerosis Among Afghan Immigrants in Isfahan, Iran, Multiple Sclerosis and Related Disorders (2017)
19. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
25. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)
33. Early Predictors of Conversion to Secondary Progressive Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2021)
36. Clinical and Epidemiological Aspects of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2017)